Preferential Autoimmune Response in Prostate Cancer to Cyclin B1 in a Panel of Tumor-Associated Antigens
Previous studies have demonstrated that sera from patients with prostate cancer (PCa) contain autoantibodies that react with tumor-associated antigens (TAAs). Autoantibodies to cyclin B1 and fourteen other TAAs were detected by enzyme-linked immunosorbent assay (ELISA) and Western blotting in 464 se...
Saved in:
| Main Authors: | Liping Dai, Jitian Li, Rosalia Ortega, Wei Qian, Carlos A. Casiano, Jian-Ying Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2014/827827 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correlation of expression of Cyclin D1 and E-cadherin with gleason grade, serum prostate specific antigen levels and prostatic volume in prostatic carcinoma
by: C Aatirah, et al.
Published: (2023-07-01) -
Radiation therapy results in preferential tumor antigen-specific lymphodepletion in head and neck cancer
by: Joseph Zenga, et al.
Published: (2025-07-01) -
Consequence of the tumor‐associated conversion to cyclin D1b
by: Michael A Augello, et al.
Published: (2015-03-01) -
Checkpoint immunotherapy is associated with preferential activation of tumor antigen–specific CD4+ T cells in MDS
by: Elizabeth A. Griffiths, et al.
Published: (2025-08-01) -
Evaluation of Diagnostic Value in Using a Panel of Multiple Tumor-Associated Antigens for Immunodiagnosis of Cancer
by: Peng Wang, et al.
Published: (2014-01-01)